Dr Patrick Trotter

Head of Innovation & Commercialisation

Patrick Trotter has a PhD in Biochemistry and Molecular Biology and MBA specializing in Technology Management.

Following the completion of his PhD, he became a Junior Fellow of the British Heart Foundation continuing the work he initiated during his PhD investigating the mechanisms of platelet activation. In 1997 Patrick moved into industry and was involved in developing a CE marked surgical sealant before moving to Johnson and Johnson in 2001, where he managed early stage internal and external projects in the areas of acute and chronic wound care and haemostats.

Patrick then set up his own bespoke medical device consultancy, InnProMa, which he ran between 2007 and 2013. He was assisting clients and many international companies in innovation strategy, R&D planning and the identification and selection of new opportunities/ technologies/ projects for investment. These were focused in the areas of wound care, wound closure, haemostats, sealants, glues and adhesives and tissue regeneration. During this period, he also became a specialist in clinical evaluation reports having written his first one in 2010, and has since gained a significant level of expertise in regulatory affairs.

Patrick is currently the Head of Innovation, Commercialisation and Regulation at Medilink North of England. He and his team have assisted companies in the medical device, diagnostics (including infection diagnostics) and digital health spheres with innovation strategy, market and competitor analysis and developing business cases for adoption of new health technologies. He had also led the formation of Medilink Regulatory providing regulatory assistance to medical device, in-vitro diagnostics companies and digital health companies whose innovations are regulated as medical devices.

He has conducted original research into best practice front end innovation processes and published his finding in international peer reviewed management journals, developed a healthcare specific front-end framework for innovation to reduce risk and maximise the probability of commercial success and profitability. Patrick has regularly run courses and workshops focused on innovation strategy and product development for the healthcare sector. These courses provide senior executives and managers the skills to launch differentiated successful products.
Patrick is an opinion leader, regularly contributing to thought leadership articles in the areas of innovation, product development, market access and regulation in industry-focused magazines with over 20 publications and 17 patent applications, 12 of which are granted.
Patrick utilises his scientific and technical expertise together with his commercialisaton acumen to provide clients with bespoke support to maximise the potential or their organisation.